Elite Pharmaceuticals Inc banner

Elite Pharmaceuticals Inc
OTC:ELTP

Watchlist Manager
Elite Pharmaceuticals Inc Logo
Elite Pharmaceuticals Inc
OTC:ELTP
Watchlist
Price: 0.445 USD -1.11% Market Closed
Market Cap: $478.2m

Profitability Summary

Elite Pharmaceuticals Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Elite Pharmaceuticals Inc

Margins Comparison
Elite Pharmaceuticals Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Elite Pharmaceuticals Inc
OTC:ELTP
475.4m USD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
992.9B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
575.5B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
281.7B CHF
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
230.4B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
216.2B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
291.1B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
153.9B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
123.2B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Elite Pharmaceuticals Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Elite Pharmaceuticals Inc
OTC:ELTP
475.4m USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
992.9B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
575.5B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
281.7B CHF
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
230.4B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
216.2B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
291.1B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
153.9B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
123.2B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Elite Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate